White paper on high-throughput process development for integrated continuous biomanufacturing
- PMID: 33749840
- PMCID: PMC8451798
- DOI: 10.1002/bit.27757
White paper on high-throughput process development for integrated continuous biomanufacturing
Abstract
Continuous manufacturing is an indicator of a maturing industry, as can be seen by the example of the petrochemical industry. Patent expiry promotes a price competition between manufacturing companies, and more efficient and cheaper processes are needed to achieve lower production costs. Over the last decade, continuous biomanufacturing has had significant breakthroughs, with regulatory agencies encouraging the industry to implement this processing mode. Process development is resource and time consuming and, although it is increasingly becoming less expensive and faster through high-throughput process development (HTPD) implementation, reliable HTPD technology for integrated and continuous biomanufacturing is still lacking and is considered to be an emerging field. Therefore, this paper aims to illustrate the major gaps in HTPD and to discuss the major needs and possible solutions to achieve an end-to-end Integrated Continuous Biomanufacturing, as discussed in the context of the 2019 Integrated Continuous Biomanufacturing conference. The current HTPD state-of-the-art for several unit operations is discussed, as well as the emerging technologies which will expedite a shift to continuous biomanufacturing.
Keywords: high-throughput process development; integrated continuous biomanufacturing; microfluidics; modeling; process analytical technology.
© 2021 The Authors. Biotechnology and Bioengineering published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures


Similar articles
-
Developments and opportunities in continuous biopharmaceutical manufacturing.MAbs. 2021 Jan-Dec;13(1):1903664. doi: 10.1080/19420862.2021.1903664. MAbs. 2021. PMID: 33843449 Free PMC article. Review.
-
The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.Trends Biotechnol. 2019 Mar;37(3):253-267. doi: 10.1016/j.tibtech.2018.08.008. Epub 2018 Sep 18. Trends Biotechnol. 2019. PMID: 30241924 Review.
-
Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.J Pharm Sci. 2015 Mar;104(3):832-9. doi: 10.1002/jps.24311. Epub 2014 Dec 26. J Pharm Sci. 2015. PMID: 25546650 Review.
-
[The current situation and developmental trends of industrial biotechnology and biomanufacturing in China].Sheng Wu Gong Cheng Xue Bao. 2022 Nov 25;38(11):4035-4042. doi: 10.13345/j.cjb.220782. Sheng Wu Gong Cheng Xue Bao. 2022. PMID: 37699675 Chinese.
-
Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.J Pharm Sci. 2015 Mar;104(3):821-31. doi: 10.1002/jps.24282. Epub 2014 Dec 1. J Pharm Sci. 2015. PMID: 25448273 Review.
References
-
- Arunkumar, A., Singh, N., Peck, M., Borys, M. C., & Li, Z. J. (2017). Investigation of single‐pass tangential flow filtration (SPTFF) as an inline concentration step for cell culture harvest. Journal of Membrane Science, 524, 20–32. 10.1016/j.memsci.2016.11.007 - DOI
-
- Baek, Y., Singh, N., Arunkumar, A., Borys, M., Li, Z. J., & Zydney, A. L. (2017). Ultrafiltration behavior of monoclonal antibodies and Fc‐fusion proteins: Effects of physical properties. Biotechnology and Bioengineering, 114(9), 2057–2065. - PubMed
-
- Bergander, T., Nilsson‐Välimaa, K., Öberg, K., & Lacki, K. M. (2008). High‐throughput process development: Determination of dynamic binding capacity using microtiter filter plates filled with chromatography resin. Biotechnology Progress, 24(3), 632–639. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources